. Despite the vital functions of astrocytes in brain development and physiology, it is unclear how their complex morphology is established. Furthermore, we do not know whether disruptions in astrocyte morphogenesis lead to synaptic dysfunction. We investigated these questions in the developing mouse primary visual (V1) cortex during postnatal days 1-21 (P1-P21), when astrocyte morphogenesis occurs concomitantly with synaptic development 7, 8 . Using Aldh1L1-EGFP BAC-transgenic mice, in which all astrocytes express enhanced green fluorescent protein (EGFP) 9 , we found that astrocytic coverage of the V1 neuropil increased profoundly from P7 to P21 (Fig. 1a-c) , coinciding with high rates of synaptogenesis 10 . This increase was concurrent with the appearance of fine astrocytic processes (Extended Data  Fig. 1a) , and only became significant between P7 and P14, when eye opening occurs, suggesting that vision drives this growth (Fig. 1b) . Indeed, mice reared in the dark showed profoundly stunted astrocyte coverage of V1 but not of the auditory cortex (Extended Data Fig. 1b-d) Next, we investigated astrocyte growth at the single-cell level using postnatal astrocyte labeling by electroporation (PALE), which sparsely transfects and labels cortical astrocytes (Extended Data Fig. 1e-h ). The volume of fluorescently labelled astrocyte processes infiltrating the neuropil (neuropil infiltration volume, NIV) increased markedly between P7 and P21 (Extended Data Fig. 1i-m) . Dark rearing decreased NIV at P21, but not at P7 (Fig. 1d, e) . V1 astrocytes also increased their territory size by about 1.6-fold between P7 and P21 (Extended Data Fig. 1n, o) . Notably, astrocyte territories were significantly reduced by dark rearing at both ages (Extended Data Fig. 1p, q) , suggesting that light-induced changes in V1, which occur even before eye opening 11 , are crucial for astrocyte territory growth. Together, our findings reveal that astrocyte morphogenesis occurs in parallel with the growth and activity of the underlying synaptic circuits of the cortex.
To investigate the mechanisms that link astrocyte morphogenesis to neuronal circuit development, we established a primary rat cortical neuron-astrocyte co-culture system, which takes advantage of the observation that astrocyte complexity is greatly enhanced by co-culture with neurons compared to culturing them alone or on Cos7 cells (Extended Data Fig. 2a-e, h ). Neuron-conditioned medium was not sufficient to induce astrocyte elaboration (Extended Data Fig. 2e, h ). Furthermore, inhibition of astrocyte glutamate sensing by blocking metabotropic glutamate receptor 5 (mGluR5) only slightly impaired astrocyte elaboration, whereas blocking synaptic network activity with tetrodotoxin (TTX) did not diminish neuron-induced astrocyte elaboration (Extended Data Fig. 2f, i ). These findings indicate that contact-mediated mechanisms, rather than secreted factors or synaptic activity, are the primary drivers for astrocyte morphogenesis in vitro. To test this theory, we fixed neurons with methanol to preserve their structure, while eliminating dynamic feedback to astrocytes. Astrocytes fully elaborated by co-culture with methanol-fixed neurons, whereas methanol-fixed Cos7 cells did not induce elaboration (Extended Data Fig. 2g , j-l). Extraction of neuronal structures with urea, while preserving the deposited extracellular matrix, severely reduced astrocyte elaboration (Extended Data Fig. 2g , j, m). Superresolution imaging of astrocyte processes and synapses showed that astrocyte elaboration occurs near synapses, and astrocytes interact closely with synaptic structures in vitro (Extended Data Fig. 2n ). Together, these results show that astrocyte morphogenesis is triggered by direct contact with neurons in vitro.
in situ hybridization (FISH) in vivo and by PCR with reverse transcription (RT-PCR) and western blotting in vitro (Extended Data Fig. 3g-j) .
Neuroligins have been mainly studied in the context of neurons [15] [16] [17] , with few exceptions [18] [19] [20] . Simultaneous knockdown of all astrocytic neuroligins with short hairpin RNAs (shRNAs) (Extended Data Fig. 4a ) completely blocked neuron-induced astrocyte elaboration in vitro (Fig. 2a, b) . Silencing each individual astrocytic neuroligin partially but significantly diminished astrocyte arborization, indicating that the neuroligins have non-overlapping roles in astrocyte morphogenesis in vitro ( Fig. 2a-e, Extended Data Fig. 4d ). Co-transfection of neuroligin-targeting shRNAs with the corresponding RNA interference-resistant neuroligin cDNAs 21 (Extended Data Fig. 4b , c) rescued astrocyte elaboration (Fig. 2a, c-e) . Knockdown of neuroligins also inhibited astrocyte elaboration induced by co-culture with methanolfixed neurons (Extended Data Fig. 4e, f) . By contrast, knockdown of EphrinA3, a CAM with known roles in astrocyte-neuron interactions 22 , did not alter astrocyte morphogenesis (Extended Data Fig. 4g, h) . Collectively, these results show that astrocytic NL1, NL2, and NL3 are required for the establishment of neuronal contact-induced astrocyte morphogenesis in vitro.
In neurons, neuroligins function by forming trans-synaptic adhesions with neurexins 16 . Swapping the extracellular cholinesterase (ChoE)-like domain of NL1 with the homologous cholinesterase sequence creates a chimaera, NL1-SWAP, that is expressed and trafficked correctly, but cannot interact with presynaptic neurexins 23 (Extended Data Fig. 4i ). Co-transfection of NL1-SWAP with an shRNA targeting NL1 (shNL1) failed to rescue astrocyte morphogenesis (Fig. 2f, g ), even though shNL1 did not diminish NL1-SWAP expression, and expression of NL1-SWAP alone in astrocytes did not impair astrocyte morphogenesis (Extended Data Fig. 4b, j, k) . These results show that contacts mediated by the ChoE-like domain of NL1 are required for astrocyte morphogenesis and suggest that interactions between astrocytic neuroligins and neuronal neurexins regulate astrocyte development.
To test whether neuronal neurexins are required for astrocytic morphogenesis, we silenced neurexin expression in cultured rat neurons using a lentivirus encoding shRNAs against mouse neurexins (Nrx1, Nrx2, and Nrx3 (both α-and β-isoforms 24 )). In rat neurons, this lentivirus silenced Nrx1 and Nrx2 but not Nrx3, owing to mismatches between the rat and mouse sequences (Extended Data Fig. 5a-d) . Silencing Nrx1 and Nrx2 in neurons significantly diminished neuronal contact-induced astrocyte morphogenesis (Fig. 2h, i) . Concurrently silencing NL1 in astrocytes did not further reduce astrocyte complexity (Extended Data Fig. 5e-g ), indicating that Nrx1 and Nrx2 are the primary neuronal interaction partners for astrocytic NL1. In addition, these findings suggest that interactions between other astrocytic neuroligins and neuronal neurexins are also important for astrocyte morphogenesis in vitro.
Elimination of neuronal neurexins may affect astrocyte morphology independent of the loss of neurexin-neuroligin contacts. To address this possibility, we used methanol-fixed neurons to induce astrocyte morphogenesis and blocked neurexin-neuroligin interactions by applying soluble Fc-tagged Nrxβ ectodomains (Extended Data Fig. 5h-j) . Co-application of Nrx1β-Fc, Nrx2β-Fc and Nrx3β-Fc significantly diminished astrocyte complexity compared to Fc-only protein (Extended Data Fig. 5k-m) . Application of Nrx1β-Fc or Nrx2β-Fc alone reduced astrocyte elaboration, but Nrx3β-Fc did not (Extended Data Fig. 5n ). Meanwhile, silencing astrocytic NL1 did not further diminish astrocyte elaboration (Extended Data Fig. 5o ). Next, we tested whether trans-interactions with neurexins are sufficient for astrocyte morphogenesis by coating 3D nanofibres with Nrxβ ectodomains to generate an artificial scaffold mimicking a web of neurites (Fig. 2j) . Remarkably, all Nrxβ-coated nanofibres strongly induced astrocyte complexity compared to those coated with Fc only (Fig. 2j, k) . Together, these results show that interactions with neuronal neurexins are required and sufficient for contact-induced astrocyte morphogenesis in vitro.
Neuroligins control astrocyte morphology in vivo
To determine whether neuroligins control astrocyte morphogenesis in vivo, we introduced EGFP-expressing shRNA plasmids targeting in astrocyte coverage of the neuropil at each  cortical layer from P1-P21 (normalized to P1  L1) . c, Fold change in astrocyte coverage of the neuropil from P7 and P21 (normalized to P7). b, c, n = 10 regions of interest (ROIs) per layer, more than 3 images per mouse, 3 mice per time point. d, Representative images and NIVs of V1 L4 PALE astrocytes from normal (NR) and dark reared (DR) mice at P7 and P21. Astrocytes were electroporated with EGFP (green) and membrane-tagged mCherry (mCherry-CAAX, red) plasmids. e, Average NIV of P7 and P21 astrocytes from normal and dark-reared mice. n = 3 NIVs per cell, 18-20 cells per condition, 4 mice per condition. One-tailed t-test (c), one-way ANOVA (e). Data are means ± s.e.m. Scale bars, 100 μm (a), 10 μm (d).
Article reSeArcH mouse NL1, NL2 or NL3 into V1 astrocytes by PALE. As a control, we used a scrambled NL1 shRNA sequence (shCtrl, Extended Data Fig. 6a-d) . As expected, shCtrl-transfected astrocytes developed main branches by P7 and elaborated finer processes into the neuropil by P21 (Fig. 3a) . NL1 knockdown markedly reduced astrocytic NIV at P7, but this was corrected by P21. Conversely, NL3 knockdown did not alter astrocyte morphogenesis at P7, but severely arrested astrocyte growth by P21. Silencing NL2 restricted NIV at both time points (Fig. 3a-f , Extended Data Fig. 6e ). These results show that neuroligins are required for astrocyte morphogenesis in vivo and suggest that the three neuroligins have unique temporal roles in astrocyte development.
To determine how increasing neuroligin expression alters astrocytic morphogenesis, we overexpressed NL1, NL2, NL3 or NL1-SWAP (control) in astrocytes by PALE. Astrocyte territories were greatly enlarged by overexpression of NL1 or NL2 compared to NL1-SWAP (Extended Data Fig. 6f, g ). The NIV of NL1-overexpressing astrocytes did not change, whereas NIV decreased slightly for NL2-overexpressing astrocytes (Extended Data Fig. 6f, h ). We were unable to find NL3-overexpressing astrocytes at P21, indicating that NL3 overexpression starting at P1 is not compatible with astrocyte survival and/or maturation. Together, these findings show that neuroligin expression in astrocytes controls neuropil infiltration and territory size of these cells.
Astrocytic NL2 controls synaptogenesis
Because NL2 knockdown markedly impaired astrocyte morphogenesis at P7 and P21, we next investigated the specific in vivo functions of NL2 in astrocytes using Nlgn2-floxed mice (in which the gene that encodes NL2, Nlgn2, is flanked with lox sequences) 25 . To address the cell-autonomous effects of NL2 on astrocyte development, we sparsely deleted NL2 by introducing Cre via PALE into Nlgn2 Article reSeArcH specificity and effectiveness of our shNL2 construct (Extended Data Fig. 7a-f ). Similar to our results with shNL2 PALE experiments, deletion of NL2 in V1 layer 4 (L4) astrocytes decreased NIV. Loss of a single allele of Nlgn2 (NL2 PALE HET) was sufficient to cause a partial but significant decrease in astrocyte infiltration (Fig. 4a, b) . Furthermore, loss of both Nlgn2 alleles caused a significant reduction in territory size (Fig. 4c, d) . Together, our results show that NL2 has an important function in astrocyte morphogenesis in vivo.
Because astrocytes are key controllers of excitatory and inhibitory synaptogenesis 27 , we next determined whether astrocytic NL2 is required for proper synaptogenesis. We quantified the synapse density within the territories of NL2 PALE HET and NL2 PALE KO L4 astrocytes and compared it with the density of synapses within the surrounding neuropil infiltrated by WT astrocytes (Fig. 4e ). Synapses were labelled by the co-localization of pre-and postsynaptic markers (that is, VGluT1 and PSD95 (intracortical excitatory), VGluT2 and PSD95 (thalamocortical excitatory) and VGAT and gephyrin (inhibitory)). Co-localization of these markers reflects true synapses, as rotating the presynaptic channel by 90° with respect to the postsynaptic channel eliminated most co-localization (Extended Data Fig. 8 ).
The density of excitatory synapses within the territory of NL2 PALE KO astrocytes was half that of the neighbouring WT astrocytes, whereas loss of a single allele of NL2 did not affect excitatory synapse density within an astrocyte's domain (Fig. 4f-i ). Inhibitory GABA (γ-aminobutyric acid)-ergic synapse density was not altered within the domains of NL2 PALE HET or NL2 PALE KO astrocytes (Fig. 4j, k) . These results were unexpected and distinct from the known neuronal role of NL2 as a regulator of inhibitory synapse formation 28, 29 . We found that astrocytic NL2 is essential for local regulation of synapse development in a cell non-autonomous manner by controlling the formation and/or maintenance of excitatory synapses within the territory of a given astrocyte.
Astrocytic NL2 controls synapse function
To investigate how astrocytic NL2 affects the function of cortical synapses, we conditionally deleted Nlgn2 (NL2 cKO) in a large population of astrocytes by combining the Nlgn2 floxed allele containing the RTM transgene with Tg(Slc1a3-cre/ERT)1Nat (GLAST-CreER T2 ) mice 30 . Cre-recombination was activated by administering tamoxifen at P10 and P11 and monitored by td-Tomato expression (Extended Data Fig. 9a, b) . NL2 (but neither NL1 nor NL3) mRNA was significantly reduced in td-Tomato/Cre + astrocytes isolated from NL2 cKO cortices by fluorescence-activated cell sorting (FACS) compared to littermate NL2 conditional heterozygous (cHET) mice. However, low levels of NL2 mRNA expression were detected, probably owing to incomplete recombination of both floxed alleles in some Cre + astrocytes (Extended Data Fig. 9a-e) . Notably, GFAP expression did not differ between NL2 cHET and cKO astrocytes (Extended Data Fig. 9e ), indicating that NL2 cKO cells retained their astrocyte identity and did not undergo pathological reactivation characterized by enhanced GFAP expression 6, 31 . Genotyping the sorted cells using allele-specific primers verified the recombination of the Nlgn2 locus (Extended Data Fig. 9f-i) . In V1 visual cortex essentially all td-Tomato/Cre + cells expressed GFAP, indicating that Cre expression is restricted to astrocytes. By contrast, 58.7 ± 4.0% (mean ± s.e.m.) of the NL2 cHET or 53.9 ± 4.4% of NL2 cKO astrocytes were td-Tomato/Cre + . Deletion of NL2 did not alter the number or distribution of astrocytes or neurons and the td-Tomato signal was absent from neurons within V1 cortex (Extended Data Fig. 10a-e) .
We next performed whole-cell patch-clamp recordings of miniature excitatory and inhibitory postsynaptic currents (mEPSCs and mIPSCs, respectively) in V1 L5 pyramidal neurons from P21 NL2 cHET and cKO mice (Extended Data Fig. 10f ). L5 neurons possess large dendritic trees that project to all cortical layers and receive extensive excitatory and inhibitory synaptic inputs 32 . The frequency and amplitude of mEPSCs were significantly reduced in NL2 cKO neurons compared to NL2 cHET neurons ( Fig. 5a -e). These observations are consistent with our finding that loss of astrocytic NL2 locally decreases excitatory synapse numbers by 50%. Similarly, deletion of NL2 in around 55% of cortical astrocytes reduces the frequency of excitatory synaptic events by about 25%. Together, our data show that astrocytic NL2 is required for the proper formation and function of excitatory synapses in the cortex.
We also detected an increase in the frequency of mIPSCs from NL2 cKO neurons compared to cHET neurons, whereas the amplitudes of mIPSCs were indistinguishable ( Fig. 5f-j) . The elevated frequency of mIPSCs in NL2 cKO neurons might be mediated by an increase in the number of inhibitory synapses. If this is the case, loss of astrocytic NL2 more broadly should enhance inhibitory synaptogenesis. Alternatively, the increase in the frequency of mIPSCs might be due to changes in the presynaptic release properties of inhibitory synapses. Together, these findings reveal a critical and previously unknown role for astrocytic NL2 as an essential governor of excitatory and inhibitory synaptic function in the cortex.
We have uncovered several unknown cell biological aspects of astrocyte-neuron interactions that control the development of cortical astrocytes, and have shown that astrocytic neuroligins have a crucial role in synaptogenesis. Bidirectional signalling via the astrocytic neuroligin and neuronal neurexin adhesions might directly regulate synapse formation and function. Alternatively, astrocytic neuroligins might control Article reSeArcH (not  visible) . f, h, j, Images of intracortical excitatory synapses (f, VGluT1 (red) and PSD95 (green)), thalamocortical excitatory synapses (h, VGluT2 (magenta) and PSD95 (green)), and inhibitory synapses (j, VGAT (magenta) and gephyrin (cyan)). Dotted lines show astrocyte territory boundaries and arrows mark co-localized synaptic puncta. g, i, k, Quantification of average intracortical (g), thalamocortical (i), and inhibitory (k) synaptic co-localized puncta within td-Tomato/Cre + PALE and Cre 
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synaptic connectivity by altering the expression and/or directed release of synaptogenic factors, such as thrombospondins, SPARCL1 (also known as Hevin) and glypicans [33] [34] [35] , from astrocytes. Future studies exploring the link between neuroligin-mediated astrocyte-neuron adhesions and the regulation of astrocyte-induced synaptogenesis are necessary to test these possibilities.
Our findings also challenge the assumption that neuroligins are functional only within neurons in the brain. This is particularly important because gene mutations in neuroligins, including NLGN2, are associated with a number of neurological disorders such as autism and schizophrenia 36, 37 . Neuroligin dysfunction in disease has been postulated to alter the fine balance between inhibition and excitation in the brain 38 . Here we demonstrate that astrocytic NL2 controls the balance of excitatory and inhibitory synaptic connectivity, indicating that synaptic pathologies associated with neuroligin mutations could originate from astrocytic dysfunction. A recent study found that glial progenitor cells from schizophrenic patients express significantly lower levels of NL1, NL2, and NL3 compared to controls. When these human glial progenitors were injected into mice, they caused neuronal dysfunction, perturbed animal behaviour and yielded abnormal astrocytic morphologies 39 . In conclusion, our findings reveal how imperative it is to understand the full extent of neuroligin functions in all cell types of the brain to completely comprehend the pathophysiology of these disorders.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. +/+ (WT) and NL1 −/− (KO) mice also containing the Aldh1L1-EGFP transgene labelling all astrocytes (green). NL1-specific RNA-FISH probes (red) were used to detect NL1 in both genetic backgrounds. Note: there is substantial fluorescence detection inside (dotted line, arrows) and outside NL1 wild-type astrocytes (top), but no detection of NL1 RNA-FISH signal in NL1 KO tissue sections (bottom). i, RT-PCR amplicons generated using transcript-specific exon-skipping primers.
Data Availability
Lanes: P7 rat cortex (Cx), DIV11 rat cortical neuron cultures (Neu.), DIV11 rat cortical astrocyte cultures (Astro.), and DIV11 rat cortical astrocyte cultures without the reverse transcriptase enzyme to control for gDNA contamination (−RT). Specific primer sets were used to detect the following transcripts: NL1, NL2, NL3, neuron-specific enolase (NSE, neuron control), CX3C chemokine receptor 1 R1 (CX3CR1, microglia control), myelin oligodendrocyte glycoprotein (MOG, oligodendrocyte control), glial fibrillary acid protein (GFAP, astrocyte control), aldehyde dehydrogenase 1 family member 1 (Aldh1L1, astrocyte control), and β-actin (loading control). Astrocyte cultures do not contain detectible neuron, microglial or oligodendrocyte contamination. Cortical neuron cultures contain around 10% glial (astrocyte and oligodendrocyte) contamination. j, Western blot images. Lanes: P7 rat cortex (Cx), DIV11 rat cortical neuron cultures (Neu.), DIV11 rat cortical astrocyte cultures (Astro.), and rat cortical astrocyte-conditioned medium (ACM). Specific and validated antibodies were used to detect the following proteins: NL1 intracellular domain (NL1 ICD), NL1 extracellular domain (NL1 ECD), NL2 ICD, NL3 ECD, Hevin (astrocyte-specific secreted protein control), GFAP (intracellular astrocyte specific control), NSE (neuron control), Tuj1 (β3-tubulin, neuron control), tubulin (intracellular protein loading control). Note the presence of two bands for NL3 in the astrocyte sample. Single asterisks denote the expected full length protein. Astrocytes express a lower molecular weight NL3 (double asterisks) to a greater extent, but this lower molecular weight product is not present in the ACM, indicating that it is not a secreted NL3 species. For gel source data, see Supplementary  Fig. 1 . Data are means ± s.e.m. Scale bars, 10 μm.
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Extended Data Figure 4 | Neuroligin CAMs control neuron-induced astrocyte morphogenesis. a-c, Specificity of shRNAs against neuroligin sequences. a, Schematic representation of EGFP-expressing shRNA plasmids used to silence rat NLs in vitro. Sequences of shRNAs used on rat astrocytes against NL1, NL2, and NL3, as well as a scrambled shNL1 sequence used as a control (shCtrl). Rat-specific shRNAs against NL1, NL2, and NL3 were previously verified for efficiency and specificity 40, 41 . The shNL2 sequence matches both rat and mouse NL2 sequences and effectively silences NL2 expression in cells from both species (Extended Data Fig. 6c, d) effectively silences both mouse and rat NL2. In this plasmid backbone, the shRNA expression is driven from the human U6 minimal promoter. The commercially available plasmids do not encode a fluorescent protein reporter; therefore, we cloned EGFP under the control of a CAG promoter (see Supplementary Methods). b, shRNA sequences used to silence mouse neuroligins for PALE. Because they are a perfect match with the rat sequences, the same shRNAs also target rat neuroligins. shNL1 and shNL3 targeting vectors were verified here. shNL2 was verified previously 40, 41 (and see Extended Data Fig. 4c) . c, d, Western blot analysis of lysates from cultured rat (c) or mouse (d) astrocytes transduced with lentiviruses expressing shCtrl or shNLs. The shNLs effectively silenced the expression of endogenous NL1 (left), NL2 (middle) and NL3 (right) in both rat and mouse astrocytes. β-tubulin levels are shown as a loading control. Blots represent one experiment. Similar results were obtained from three separate experiments. e-h, Astrocytic neuroligins control astrocyte morphogenesis in vivo. e, Data from Fig. 3e , f normalized to P7 shCtrl astrocyte NIV values and replotted to determine how neuroligin silencing affects the growth trajectory of astrocyte NIV. shNL2 and shNL3-transfected astrocytes failed to expand their neuropil infiltration from P7 to P21, whereas shCtrl and shNL1-transfected astrocytes displayed robust (~2.5-fold) growth. Three NIV per cell, 10-20 cells per condition, at least three mice per condition. f, Top, representative images of P21 neuroliginoverexpressing PALE astrocytes from L4-5 V1 cortex. The territories of the neuroligin-overexpressing PALE astrocytes were determined in Imaris Bitplane software with a Matlab Xtension. This method identifies the terminal fluorescent points of each astrocyte and connects these points to generate the territory of each cell (red outline). Bottom, representative NIV (magenta) for neuroligin-overexpressing PALE astrocytes. g, Fold change in average territory volume of NL1-or NL2-overexpressing PALE astrocytes normalized to HA-NL1-SWAP. In the brains from three cohorts of seven PALE NL3-overexpressing mice, we were unable to find NL3-overexpressing astrocytes at P21, indicating that NL3-overexpression starting at P1 is not compatible with astrocyte survival and/or maturation. h, Fold change in average NIV of neuroligin-overexpressing PALE astrocytes normalized to HA-NL1-SWAP. Astrocytes might already occupy the available neuropil space; thus, neuroligin overexpression primarily forces astrocytes to expand. Alternatively, each neuroligin might direct astrocyte processes to certain neuronal elements; thus, neuroligin overexpression drives the astrocyte towards such structures, expanding their domains. g, h, Three NIVs per cell (h only), 14-20 cells per condition, 4 mice per condition. ANCOVA (e), one-way ANOVA (g, h). For gel source data, see Supplementary Fig. 1 . Data are means ± s.e.m. Scale bars, 10 μm. Figure 10 | Conditional deletion of NL2 in astrocytes  does not alter cell number or distribution. a-c Bottom left, experimental timeline of tamoxifen-induced recombination of Cre-dependent loci (floxed Nlgn2 and RTM) in combination with the GLAST-CreER T2 transgene. Cre was activated by administering 0.6 mg tamoxifen at P10 and P11 via intraperitoneal injection to achieve widespread deletion of NL2 in astrocytes. Right, schematic representation of electrophysiological recording experiments performed on L5 V1 pyramidal neurons from NL2 cHET and NL2 cKO mice. L5 pyramidal neurons receive excitatory and inhibitory synaptic connections from all cortical layers that contain td-Tomato/Cre + (red) and td-Tomato/Cre − (grey) astrocytes. mEPSCs and mIPSCs were recorded from L5 pyramidal neurons using acute slices from P21 NL2 cHET and NL2 cKO mice containing the V1 cortex. ANCOVA (b, c, e). Data are means ± s.e.m. Scale bars, 100 μm. Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
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No samples or analyses were excluded from in vitro experiments. Two animals were excluded from Extended Data Fig 9e based on identification of the lack of tamoxifen-induced allelic recombination to produce NL2KOs after the problem was traced back to a bad batch of tamoxifen. In sum their inclusion or exclusion does not alter the final conclusions of these analyses.
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All experimental findings were reliably reproducible.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
For in vivo studies, animals were chosen based on correct genotypes, requiring 2 or 3 correct alleles. Specifically, animal pairs from the same litters were compared to decrease variance in age and rearing. However, each experiment contained animals from at least two different litters to ensure that the differences between genotypes can be observed in mice from different litters. Sex-specific differences were eliminated by including equal numbers of both sexes for all animal studies.
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Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
For all in vitro experiments, the investigator performing the imaging and analyses was blind to the experimental conditions. For in vivo immunohistochemistry experiments, the investigator was blind to the experimental groups during the analyses. During the execution and analyses of the electrophysiological recordings, the electrophysiologist was blind to the genotypes of the individual animals.
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